Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

6.18
Delayed Data
As of Aug 31
 -0.24 / -3.74%
Today’s Change
5.25
Today|||52-Week Range
18.42
-56.33%
Year-to-Date

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Keryx Biopharmaceuticals Inc have a median target of 11.50, with a high estimate of 22.00 and a low estimate of 3.00. The median estimate represents a +86.08% increase from the last price of 6.18.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in Keryx Biopharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.24
Sales
$4.6M
Reporting Date
Nov 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 6.64%
 
 
 
 
 
 
Growthannually 20.10%
 
 
 
 
 
 

Sales

Growthquarterly 82.87%
 
 
 
 
 
 
Growthannually 57.63%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.